We are live on
!
Find out more
DTC
Deep Track Capital Portfolio holdings
AUM
$4.85B
1-Year Est. Return
144%
This Fund
S&P 500
1 Year Est. Return
+144%
AUM
$4.85B
AUM Growth
+$462M
(+11%)
Holding
69
Top Buys
| 1 | +$169M | |
| 2 | +$140M | |
| 3 | +$111M | |
| 4 |
Genmab
GMAB
|
+$110M |
| 5 |
Vera Therapeutics
VERA
|
+$55.4M |
Top Sells
| 1 | +$242M | |
| 2 | +$125M | |
| 3 | +$69.3M | |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$67.1M |
| 5 |
MAZE
Maze Therapeutics
MAZE
|
+$33.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
BioMarin Pharmaceuticals
BMRN
$10.8B
| $65M | 1.34% |
1,150,000
-1,150,000
|
|
||
27
BridgeBio Pharma
BBIO
$13.1B
| $62.5M | 1.29% |
841,445
+31,303
|
|
||
28
Immunocore
IMCR
$1.47B
| $58.2M | 1.2% |
1,931,884
-72,094
|
|
||
29
Tango Therapeutics
TNGX
$5.04B
| $57.5M | 1.19% |
2,750,000
+295,438
|
|
||
|
DFTX
30
Definium Therapeutics
DFTX
$2.7B
| $56.7M | 1.17% |
3,000,000
+1,323,460
|
|
||
|
TERN
31
DELISTED
Terns Pharmaceuticals
TERN
| $56.6M | 1.17% |
1,073,877
+304,829
|
|
||
32
Geron
GERN
$738M
| $47.3M | 0.98% |
31,720,278
-790,993
|
|
||
33
ANI Pharmaceuticals
ANIP
$1.86B
| $46.1M | 0.95% |
600,000
+122,316
|
|
||
34
CorMedix
CRMD
$686M
| $42.6M | 0.88% |
6,274,076
+1,000,000
|
|
||
35
AtaiBeckley Inc
ATAI
$1.44B
| $42.5M | 0.88% |
12,000,000
+7,322,711
|
|
||
36
Celldex Therapeutics
CLDX
$2.45B
| $40.7M | 0.84% |
1,283,979
-616,759
|
|
||
37
Cogent Biosciences
COGT
$5.66B
| $38.5M | 0.79% |
1,000,000
+546,898
|
|
||
38
Corvus Pharmaceuticals
CRVS
$1B
| $36.5M | 0.75% |
+2,491,539
|
|
||
39
Dyne Therapeutics
DYN
$3.01B
| $36.3M | 0.75% |
2,000,000
-650,000
|
|
||
|
SLNO
40
DELISTED
Soleno Therapeutics
SLNO
| $36.1M | 0.75% |
1,078,710
+78,710
|
|
||
41
Aclaris Therapeutics
ACRS
$603M
| $35M | 0.72% |
+9,345,000
|
|
||
|
MANE
42
Veradermics Inc
MANE
$4.01B
| $31.6M | 0.65% |
+500,000
|
|
||
43
Verastem
VSTM
$360M
| $30.4M | 0.63% |
5,740,850
|
|
||
44
enGene Therapeutics
ENGN
$109M
| $29.8M | 0.62% |
4,377,572
|
|
||
45
Viridian Therapeutics
VRDN
$1.81B
| $27.3M | 0.56% |
1,393,944
-1,130,889
|
|
||
46
X4 Pharmaceuticals
XFOR
$377M
| $26.2M | 0.54% |
6,339,535
+1,325,874
|
|
||
47
Solid Biosciences
SLDB
$703M
| $25.7M | 0.53% |
+3,565,062
|
|
||
48
Enanta Pharmaceuticals
ENTA
$346M
| $24.7M | 0.51% |
1,956,867
|
|
||
49
Apogee Therapeutics
APGE
$6.66B
| $24M | 0.5% |
+285,000
|
|
||
50
Kura Oncology
KURA
$803M
| $21.5M | 0.44% |
+2,643,542
|
|